Neuroblastoma is a malignant tumor that often grows rapidly. In the early stages of the disease, it can easily invade surrounding tissues and nerves, making it very difficult to completely remove the tumor through surgery. In most cases, even after surgical treatment, there is a high tendency for recurrence in children, making it difficult to achieve a clinical cure. For most patients with neuroblastoma, early post-surgical treatment involving high doses of radiotherapy and chemotherapy can effectively reduce the likelihood of tumor recurrence and appropriately prolong the patient’s lifespan. This helps in extending the lifespan and improving the quality of life to some extent, but generally, the final prognosis remains poor.